Krystal Biotech Announces Home Dosing in B-VEC Open Label Extension Study

Go back to Krystal Biotech Announces Home Dosing in B-VEC Open Label Extension Study
(NASDAQ: KRYS) Delayed: 341.12 -25.73 (7.01%)
Previous Close $366.85    52 Week High
Open $364.66    52 Week Low
Day High $367.30    P/E N/A 
Day Low $340.55    EPS
Volume 488,644